After-hours movers: Palantir, NXP Semiconductors, Lumentum and more

Go back to After-hours movers: Palantir, NXP Semiconductors, Lumentum and more

NXP Semiconductors NV (NXPI) PT Lowered to $245 at Truist Securities

February 4, 2025 3:28 PM EST

Truist Securities analyst William S. Stein lowered the price target on NXP Semiconductors NV (NASDAQ: NXPI) to $245.00 (from $264.00) while maintaining a Buy rating.

The analyst comments "Like so many others, NXPI is pushing-out the anticipated recovery. NXP delivered ~inline Q4 results overall, but guided... More

William Blair Reiterates Underperform Rating on Palantir Technologies Inc. (PLTR), 'potential for a repeat of valuation multiple compression'

February 4, 2025 7:09 AM EST

William Blair analyst Louie DiPalma reiterated an Underperform rating on Palantir Technologies Inc. (NASDAQ: PLTR)

The analyst comments "Palantir shares are trading 23% higher after hours after the company reported revenue and operating income above consensus. The company guided 2025 revenue to $3.75 billion, compared with consensus of $3.51 billion. The... More

Palantir Technologies Inc. (PLTR) PT Raised to $120 at Wedbush

February 4, 2025 6:44 AM EST

Wedbush analyst Dan Ives raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $120.00 (from $90.00) while maintaining a Outperform rating.

The analyst comments "There are some transformational tech stocks that come along every decade and change the... More

Palantir Technologies Inc. (PLTR) PT Raised to $125 at BofA Securities

February 4, 2025 5:23 AM EST

BofA Securities analyst Mariana Perez Mora raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $125.00 (from $90.00) while maintaining a Buy rating.

The analyst comments "Our PO of $125 is based on 15x EV/EBITDA on 2035E. We are moving... More

Clorox (CLX) PT Raised to $189 at Jefferies

February 4, 2025 5:09 AM EST

Jefferies analyst Kaumil Gajrawala raised the price target on Clorox (NYSE: CLX) to $189.00 (from $188.00) while maintaining a Buy rating

The analyst comments "Despite a mixed quality print, Clorox delivered another beat and raise quarter. The company raised guidance across the board as... More